Identifying factors in the provision of intravenous stroke thrombolysis in Malaysia: a multiple case study from the healthcare providers' perspective
- PMID: 38183003
- PMCID: PMC10768456
- DOI: 10.1186/s12913-023-10397-8
Identifying factors in the provision of intravenous stroke thrombolysis in Malaysia: a multiple case study from the healthcare providers' perspective
Abstract
Background: Translation into clinical practice for use of intravenous thrombolysis (IVT) for the management of ischemic stroke remains a challenge especially across low- and middle-income countries, with regional inconsistencies in its rate. This study aimed at identifying factors that influenced the provision of IVT and the variation in its rates in Malaysia.
Methods: A multiple case study underpinning the Tailored Implementation for Chronic Diseases framework was carried out in three public hospitals with differing rates of IVT using a multiple method design. Twenty-five in-depth interviews and 12 focus groups discussions were conducted among 89 healthcare providers, along with a survey on hospital resources and a medical records review to identify reasons for not receiving IVT. Qualitative data were analysed using reflective thematic method, before triangulated with quantitative findings.
Results: Of five factors identified, three factors that distinctively influenced the variation of IVT across the hospitals were: 1) leadership through quality stroke champions, 2) team cohesiveness which entailed team dynamics and its degree of alignment and, 3) facilitative work process which included workflow simplification and familiarity with IVT. Two other factors that were consistently identified as barriers in these hospitals included patient factors which largely encompassed delayed presentation, and resource constraints. About 50.0 - 67.6% of ischemic stroke patients missed the opportunity to receive IVT due to delayed presentation.
Conclusions: In addition to the global effort to explore sustainable measures to improve patients' emergency response for stroke, attempts to improve the provision of IVT for stroke care should also consider the inclusion of interventions targeting on health systems perspectives such as promoting quality leadership, team cohesiveness and workflow optimisation.
Keywords: Acute stroke care; Determinants; Developing countries; Factors; Intravenous thrombolysis; Translational research.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures


Similar articles
-
Stroke thrombolysis in a middle-income country: A case study exploring the determinants of its implementation.Front Neurol. 2022 Nov 24;13:1048807. doi: 10.3389/fneur.2022.1048807. eCollection 2022. Front Neurol. 2022. PMID: 36504666 Free PMC article.
-
Barriers to Thrombolysis at A Tertiary Care Public Hospital- A Prospective Observational Study from Southern Part of India.Neurol India. 2022 May-Jun;70(3):972-977. doi: 10.4103/0028-3886.349615. Neurol India. 2022. PMID: 35864627
-
An overview of hyperacute stroke services and National Stroke Registry in Malaysia - Improving stroke care through evidence.Med J Malaysia. 2025 Mar;80(2):266-274. Med J Malaysia. 2025. PMID: 40145171
-
Utilization rates of intravenous thrombolysis for acute ischemic stroke in Asian countries:: A systematic review and meta-analysis.Medicine (Baltimore). 2023 Oct 20;102(42):e35560. doi: 10.1097/MD.0000000000035560. Medicine (Baltimore). 2023. PMID: 37861564 Free PMC article.
-
Circadian Rhythm and Risk of Hemorrhagic Transformation after Acute Ischemic Stroke Treated with Intravenous Thrombolysis - A Systematic Review.CNS Neurol Disord Drug Targets. 2023;22(10):1493-1506. doi: 10.2174/1871527322666221004113752. CNS Neurol Disord Drug Targets. 2023. PMID: 36200200
References
-
- Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384:1929–1935. doi: 10.1016/S0140-6736(14)60584-5. - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical